Kura Oncology Inc (KURA)

EBITDA Margin

-381.19%

TTM · Period ending:

KURA logo

KURA EBITDA Margin

Latest reported-381.19%
KURA TTM EBITDA Margin (-2441.17% → -381.19%)
High-resolution chart · PNG

KURA ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Kura Oncology Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-381.1887%
-407.9789%
-410.4532%
-205.1303%
-232.0237%
-261.7243%
-314.5667%
-2,493.165%
-2,431.9787%
-2,418.6576%
-2,441.1741%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.